United Imaging Healthcare

Chinese medical imaging manufacturer founded in 2011 — the most aggressive full-stack imaging entrant of the past decade. Builds CT, MRI, PET / CT, SPECT, PET / MR, digital radiography, and radiotherapy in-house, with disruptive pricing against the Big Three (GE / Siemens / Philips) in China and emerging markets, and growing footprint in North America and Europe. Publicly listed on the Shanghai STAR Market.

Company history

2011 — founded in Shanghai by former Siemens imaging executives.
2015 — ships first-generation uMR 1.5T MRI, uCT, and uMI PET / CT.
2018 — uEXPLORER prototype — first commercial total-body PET / CT with ~194 cm axial FOV (versus ~25 cm on conventional premium PET / CT). Substantial sensitivity gain for research and oncology applications.
2019 — FDA clearances for uMI, uCT, and uMR families.
2020 — first U.S. uEXPLORER install at UC Davis Medical Center.
2022 — IPO on Shanghai STAR Market.
2020s — uMR Jupiter 5T MRI clinical introduction (one of the highest-field human MRI platforms in commercial production), continuing uEXPLORER and uMI Panorama digital PET deployments globally.

Product line

CT — uCT family (uCT 960+, uCT 960, uCT ATLAS, uCT 530 / 760 mid-tier).
MRI — uMR family (uMR Jupiter 5T, uMR Ultra 3T, uMR Omega / Cetus 1.5T).
PET / CT — uMI family (uMI 780, uMI Panorama GS digital), and the uEXPLORER total-body PET / CT.
PET / MR — uPMR 790.
SPECT / SPECT-CT — uSPECT 980 family.
Digital radiography — uDR series (rooms and mobile).
Linac / radiotherapy — uRT linac line.
Software — uAI imaging-AI platform, uMI Intelligence Platform, vendor-agnostic clinical-AI deployment layer.

Distinctive technology

uEXPLORER total-body PET / CT — ~194 cm axial FOV with ~40× the sensitivity of conventional PET / CT at matched detector technology. Enables ultra-low-dose imaging, dynamic whole-body kinetic modeling, pediatric scans at fraction-of-conventional dose, and research applications no segmented-FOV scanner can match.
5T clinical MRI (uMR Jupiter) — pushes commercial field strength beyond the 3T clinical ceiling for selected research and high-resolution neuro applications.
SiPM-based digital PET across the uMI line, with ToF and image-quality posture comparable to current Big Three digital PET platforms.
Integrated full-stack strategy — unified software across modalities (uAI, uMI Intelligence Platform), with the explicit goal of cross-modality consistency the Big Three reach via acquisition.

Market position

Dominant in China — state-level procurement and domestic-OEM preference have driven rapid installed-base growth.
Rapidly growing in Southeast Asia, Middle East, Africa, and Latin America — competitive on capital cost against Big Three refurbs.
North American and European presence — ramping through the 2020s, with academic-center wins (UC Davis uEXPLORER, others) anchoring credibility.
Refurb market — too early; first-generation installs are still under OEM service.

Refurb posture

Limited secondary market as of mid-2020s — installed base is largely first-owner and under direct OEM service.
Service-network depth outside China is the most-watched lifecycle variable for cross-border buyers.
Software platform is the differentiator — uAI tier and clinical-application licensing will become the price-determining variable as the installed base ages.

PET / CT — uEXPLORER reshapes the top end
MRI
CT
Nuclear Medicine / SPECT
GE Healthcare (competitor)
Siemens (competitor)
Philips (competitor)